Skip to main content
Fig. 6 | Cancer Cell International

Fig. 6

From: The novel long non-coding RNA LATS2-AS1-001 inhibits gastric cancer progression by regulating the LATS2/YAP1 signaling pathway via binding to EZH2

Fig. 6

YAP1 mRNA expression and patient prognosis in GC, based on Oncomine and KMPLOT database analysis. DErrico Gastric Statistics in the Oncomine database revealed that YAP1 was highly expressed in GC tissues (a). YAP1 mRNA expression was elevated in gastric intestinal adenocarcinoma (b), diffuse gastric adenocarcinoma (c) and gastric mixed adenocarcinoma (d) compared with the gastric normal mucosa. KMPLOT database analysis demonstrated that patients with high YAP1 expression had poor prognosis, with shorter overall survival (e) and reduced first progression time (f) compared with the low YAP1 expression cohort

Back to article page